{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:07:43Z","timestamp":1792058863626,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.bcmd.2008.02.003","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T01:50:57Z","timestamp":1205891457000},"page":"95-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells"],"prefix":"10.1016","volume":"41","author":[{"given":"Stella M.","family":"Ranuncolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2008.02.003_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.iy.12.040194.001001","article-title":"Germinal centers","volume":"12","author":"MacLennan","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcmd.2008.02.003_bib2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.molmed.2006.07.001","article-title":"Activation-induced deaminase: light and dark sides","volume":"12","author":"de Yebenes","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bcmd.2008.02.003_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2008.02.003_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/mutage\/gei063","article-title":"DNA damage checkpoints in mammals","volume":"21","author":"Niida","year":"2006","journal-title":"Mutagenesis"},{"key":"10.1016\/j.bcmd.2008.02.003_bib5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.dnarep.2007.02.015","article-title":"The ATR pathway: fine-tuning the fork","volume":"6","author":"Paulsen","year":"2007","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.bcmd.2008.02.003_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1101\/gad.13.2.152","article-title":"A role for ATR in the DNA damage-induced phosphorylation of p53","volume":"13","author":"Tibbetts","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcmd.2008.02.003_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1101\/gad.14.3.289","article-title":"The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites","volume":"14","author":"Shieh","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcmd.2008.02.003_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"el-Deiry","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2008.02.003_bib9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1092734","article-title":"Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis","volume":"303","author":"Chipuk","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2008.02.003_bib10","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1182\/blood.V87.12.5257.bloodjournal87125257","article-title":"BCL-6 expression during B-cell activation","volume":"87","author":"Allman","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2008.02.003_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng0697-161","article-title":"The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation","volume":"16","author":"Ye","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2008.02.003_bib12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1126\/science.276.5312.589","article-title":"Control of inflammation, cytokine expression, and germinal center formation by BCL-6","volume":"276","author":"Dent","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2008.02.003_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ni1478","article-title":"Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR","volume":"8","author":"Ranuncolo","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcmd.2008.02.003_bib14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nature03147","article-title":"The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells","volume":"432","author":"Phan","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2008.02.003_bib15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ni1245","article-title":"BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells","volume":"6","author":"Phan","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcmd.2008.02.003_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ccr.2005.03.037","article-title":"Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice","volume":"7","author":"Cattoretti","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcmd.2008.02.003_bib17","doi-asserted-by":"crossref","first-page":"14198","DOI":"10.1073\/pnas.0406138101","article-title":"The human BCL6 transgene promotes the development of lymphomas in the mouse","volume":"101","author":"Baron","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2008.02.003_bib18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1126\/science.8235596","article-title":"Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma","volume":"262","author":"Ye","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2008.02.003_bib19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/ni1508","article-title":"Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells","volume":"8","author":"Phan","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcmd.2008.02.003_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ccr.2007.08.011","article-title":"A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma","volume":"12","author":"Saito","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcmd.2008.02.003_bib21","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1073\/pnas.0437996100","article-title":"Transcriptional analysis of the B cell germinal center reaction","volume":"100","author":"Klein","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2008.02.003_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/nm1134","article-title":"Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells","volume":"10","author":"Polo","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2008.02.003_bib23","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1073\/pnas.0611399104","article-title":"Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas","volume":"104","author":"Polo","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2008.02.003_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/gcc.2870130314","article-title":"BCL6 encodes a sequence-specific DNA-binding protein","volume":"13","author":"Baron","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bcmd.2008.02.003_bib25","first-page":"1495","article-title":"The LAZ3\/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB\/POZ domain as an autonomous repressing domain","volume":"6","author":"Deweindt","year":"1995","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.bcmd.2008.02.003_bib26","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1073\/pnas.93.14.6947","article-title":"BCL-6, a POZ\/zinc-finger protein, is a sequence-specific transcriptional repressor","volume":"93","author":"Chang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2008.02.003_bib27","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1101\/gad.14.12.1448","article-title":"Chk1 is an essential kinase that is regulated by Atr and required for the G(2)\/M DNA damage checkpoint","volume":"14","author":"Liu","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcmd.2008.02.003_bib28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.molcel.2005.07.019","article-title":"Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway","volume":"19","author":"Zhang","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcmd.2008.02.003_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccr.2004.06.015","article-title":"Chk1 is haploinsufficient for multiple functions critical to tumor suppression","volume":"6","author":"Lam","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcmd.2008.02.003_bib30","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4161\/cc.3.11.1225","article-title":"Chk1 versus Cdc25: chking one's levels of cellular proliferation","volume":"3","author":"Lam","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcmd.2008.02.003_bib31","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S1097-2765(03)00454-4","article-title":"Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain","volume":"12","author":"Ahmad","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcmd.2008.02.003_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cell.2004.09.014","article-title":"MTA3 and Mi-2\/NuRD complex regulate cell fate during B-lymphocyte differentiation","volume":"119","author":"Fujita","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2008.02.003_bib33","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood-2007-01-069575","article-title":"BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms","volume":"110","author":"Parekh","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2008.02.003_bib34","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V106.11.1484.1484","article-title":"BCL6, p53 and molecular targeted therapy in B-cell lymphomas","volume":"106","author":"Cerchietti","year":"2005","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979608000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979608000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:25:01Z","timestamp":1761049501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979608000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1079979608000417"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2008.02.003","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2008.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}